Drug Litigation Lawyers: News & Articles

HOME

ABOUT US

NEWS & ARTICLES

LEGAL COMMUNITY

CONTACT US

September 8, 2008

Selecting an drug litigation attorney for your legal case is a very important decision. Please enter a zip code to find an attorney in your area:

Zip Code:

Advanced Search

	Drug Litigation News & Articles

	The following is the latest news and articles related to drug litigation issues. To find local news and articles, please visit our state drug litigation resources. FTC’s Bureau of Competition Issues Summary of Pharmaceutical Company Settlement Agreements FTC, Jul 25, 2008 Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market San Francisco Health Plan, Herrera Sue McKesson Corp. for Pharmaceutical Price-Fixing Scheme State of San Francisco, Jul 11, 2008 City Program is First Government Plaintiff in Federal Suit Alleging Multimillion Dollar Conspiracy to Hike Prices on Consumers, Providers Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations U.S. Department of Justice, Jun 17, 2008 The United States will not tolerate pharmacies or any other health care providers that attempt to manipulate the Medicaid program at the taxpayers Former Bristol-Myers Squibb Senior Vice President Indicted For Lying To The Federal Government About Popular Blood-Thinning Drug FBI, Jun 03, 2008 The Department said that the alleged illegal actions of Bodnar related to the possible introduction of a generic drug that would compete with Plavix CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations U.S. Department of Justice, May 20, 2008 Switching medication from tablets to capsules might seem harmless, but when that is done solely to increase profit and in violation of federal and state regulations FTC Sues Cephalon, Inc. for Unlawfully Blocking Sale of Lower-Cost Generic Versions of Branded Drug Until 2012 FTC, Apr 22, 2008 Complaint Charges Company Paid Four Generic Drug Makers in Order to Protect Monopoly Profits on its Leading Product FDA Warns Consumers about FDA, Apr 08, 2008 Distributor recalls dietary supplement products after reports of adverse reactions Bristol-Myers Squibb Pleads Guilty to Lying USDOJ Gov, Feb 29, 2008 Illegal Actions Threatened to Delay Generic Competition for Drug FDA Approves New HIV Drug After Priority Review fda.gov, Jan 22, 2008 The U.S. Food and Drug Administration today approved etravirine tablets for the treatment of HIV infection in adults who have failed treatment with other antiretrovirals. FDA Issues Second Safety Warning on Fentanyl Skin Patch FDA, Jan 14, 2008 The Food and Drug Administration today issued its second safety warning about the fentanyl transdermal system, an adhesive patch that delivers a potent pain medicine Attorney General Stumbo Announces Settlement With Manufacturer of Loprox for Illegal Off-Label Marketing of Diaper Rash Medication Kentucky Gov, Jan 09, 2008 Attorney General Greg Stumbo announced today that the Kentucky Medicaid Program will receive an $181,084.21 settlement from Medicis Pharmaceutical Corporation FDA Warns Consumers Not to Use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular (also known as Shangai Chaojimengnan) FDA, Jan 02, 2008 These products are illegal drugs and contain undeclared active ingredients in prescription erectile dysfunction drugs FDA Warns Consumers Not to Use Swad Brand Sindoor: Product Contains High Levels of Lead FDA, Dec 18, 2007 The U.S. Food and Drug Administration is warning consumers not to use 3.5 oz. packages of Swad brand sindoor Amagansett Doctor Charged In Presciption Drug Trafficking Scam New York State Gov, Dec 10, 2007 Amagansett Doctor Charged In Presciption Drug Trafficking Scam Myfortic Delayed-Release Tablets FDA, Dec 03, 2007 Novartis and FDA informed healthcare professionals and patients that use of Myfortic Delayed- Release Tablets during Doctor and Pharmacy Owner Plead Guilty in Internet Pharmacy Conspiracy Department of Justice, Nov 26, 2007 Florida pharmacy owner and a Kentucky physician pleaded guilty to conspiracy for their participation in an Internet pharmacy of the illegal sale of prescription drugs Athens Doctor Guilty of Prescription Fraud Tennessee Bureau of Investigation, Nov 19, 2007 Orthopedic Surgeon has pled guilty to Obtaining Drugs by Fraud and Conspiracy to Obtain Drugs by Fraud FDA Announces Results of Investigation Into Illegal Promotion of OxyContin FDA, Nov 05, 2007 Illegal scheme to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces Prescription Fraud Arrest in Montgomery County Montogomery County, Maryland Office, Oct 29, 2007 Both men were charged with CDS-obtained by making a forged prescription, and were released on their own recognizance, to await trial In Charlotte, Five Defendants Indicted in Unlawful Prescription Drug Operation Department of Justice, Oct 22, 2007 North Carolina pharmacist, and four additional defendants from Vermont, Wisconsin, New York, and California have been indicted on drug distribution Mayor Bloomberg and Attorney General Cuomo Sue Maker of Vioxx for Hiding Drug's Risks State of New York, Oct 08, 2007 First Time State and City Bring Joint Action to Fight Medicaid Fraud FDA Warns of Potential Serious Side Effects with Breakthrough Cancer Pain Drug FDA, Oct 01, 2007 FDA Warns of Potential Serious Side Effects with Breakthrough Cancer Pain Drug Revised WARNINGS Section on Haloperidol FDA, Sep 24, 2007 Johnson and Johnson and FDA informed healthcare professionals that the WARNINGS section of the prescribing information for haloperidol has been revised. Recall of Axcil and Desirin Products FDA, Sep 24, 2007 TWC Global LLC announced that it is conducting a voluntary nationwide recall. B. Braun Medical Inc. Issues Nationwide Recall of Syringes The Food and Drug Administration, Sep 14, 2007 Customers that have the recalled product in their possession should discontinue use immediately and contact their physician Bodee LLC, Inc. Issues A Recall of All Zencore Tabs Food and Drug Administration, Sep 07, 2007 Bodee LLC is conducting this recall after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA Warfarin Prescribing Information Food and Drug Administration, Aug 16, 2007 These labeling updates are based on an analysis of recent studies that found people respond to the drug differently based, in part, on whether they have variations of cer Avandia May Cause Heart Problems Staff Writer, Aug 02, 2007 Scientist Dr. David Graham distributed a document with these facts to a panel of outside experts during a meeting. The meeting was being held to determine what steps shou Drug Interaction with Rocephin (ceftriaxone sodium) for Injection FDA, Jul 23, 2007 The product was recalled because the meters reported the wrong units of measure for Canadian users. Instead of mmol/L, which is the appropriate measurement for Canadian u Risky Drug Purchases On The Internet FDA, Jul 05, 2007 The U.S. Food and Drug Administration continues to warn the American public about the dangers of buying medications over the Internet Drug Recalled Due To Undeclared Tadalafil Food and Drug Administration, Jun 15, 2007 According to the FDA, consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. FDA advises that ED is a common problem in men The Dangers of Unapproved Time-Released Drugs Food and Drug Administration, Jun 01, 2007 These dosage forms release their active ingredients over an extended period of time, reducing the number of doses needed per day. Many of the products that contain guaife FDA Announces that Companies Must Stop Marketing Suppository Products Containing Trimethobenzamide FDA, Apr 19, 2007 FDA Announces that Companies Must Stop Marketing Suppository Products Containing Trimethobenzamide hydrochloride FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons FDA, Apr 11, 2007 FDA has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm FDA Should Release More Drug Safety Data: Experts Health Finder, Apr 05, 2007 Current rules allow drug companies to keep data secret, which prevents the public from learning about dangerous side effects of drugs FDA Advisory for Tegaserod maleate marketed as Zelnorm FDA, Mar 29, 2007 Zelnorm is being taken off the market because a new safety analysis has found a higher chance of heart attack IMPAX Settles Patent Litigation Related to Generic Wellbutrin-R XL IMPAX Laboratories, Inc. , Mar 26, 2007 The litigation will be dismissed with Biovail granting to Teva an exclusive license to market the IMPAX 300 mg strength product National Consumer Coalition Objects To 63.8 Million Settlement Of PAXIL Pediatric Class Action PAL, Mar 19, 2007 Prescription Access Litigation PAL on Friday filed an objection to a proposed class action settlement involving GlaxoSmithKline 24 million settlement with Serono in case alleging illegal promotion of AIDS drug Serostim Prescription Access Litigation, Mar 16, 2007 The $24-million settlement resolves claims that Serono wrongfully encouraged doctors to prescribe the AIDS drug Serostim to patients for whom it was unnecessary FAA Releases New Drug and Alcohol Testing Rule ARSA, Mar 07, 2007 Despite strong industry opposition to the changes affected by the new rule, the FAA is now requiring that “each employee who performs a safety function to be drug tested Merck Pharmaceutical Drug War Comes to Heartland Press Release, Feb 19, 2007 The legal war between drug manufacturers and people who use the drugs has now moved into the heartland of America Biopharmaceutical Firm to Pay US for Illegal Promotion and Marketing of Drug US Department of Justice, Feb 12, 2007 InterMune, a biopharmaceutical company, has agreed to pay the United States more than $36.9 million to resolve criminal charges and civil liabilities Counterfeit Medicines US Food and Drug Administration, Jan 15, 2007 Purchase ONLY from state licensed pharmacies that are located in the US where the FDA and state authorities can assure the quality of drug manufacturing and distribution Celebrex Approved to Treat Juvenile Rheumatoid Arthritis fda.gov, Dec 28, 2006 JRA is an autoimmune disease that affects approximately 30,000 to 60,000 children in the United States. Omnicare Inc.To Pay $49.5 Million To Settle Medicaid Prescription Drug Fraud Allegations usdoj.gov, Dec 12, 2006 The settlement covers Omnicare’s submission of reimbursement claims to Medicaid programs in 43 states for three prescription drugs from April 2000 through 2005. FTC Testifies On Barriers To The Entry Of Generic Drugs ftc.gov, Nov 28, 2006 Branded and generic pharmaceutical competition and discussed barriers that can lead to the delay of generic entry into the U.S. marketplace. State Settlement With Pharmaceutical Company Ends Investigation Into Drug Pricing state.ny.us, Oct 31, 2006 Will result in the recovery of $11.9 million for losses sustained by New York's Medicaid program and an additional $3 million Berlex Voluntarily Recalls Ultravist fda.gov, Oct 20, 2006 Patient safety is our primary concern, and we are committed to taking the necessary steps in order to protect patients from any potential safety risks. Bayer Delays Release Of Study To FDA fda.gov, Oct 05, 2006 FDA was not aware of these new data when it held the September 21, 2006, Advisory Committee meeting on Trasylol safety. Bill Introduced To Bar Drug Firms From Pushing Authorized Generics Press Release, Sep 22, 2006 The legislation would provide real competition between generic companies producing low-cost medicines and the pharmaceutical giants FDA Asks U.S. Marshals To Seize Dietary Supplements fda.gov, Sep 15, 2006 The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act. FTC Testifies On Barriers To The Entry Of Generic Drugs ftc.gov, Sep 01, 2006 Generic drugs play an important role in containing rising prescription drug costs, by offering consumers therapeutically identical alternatives to brand-name drugs, at a FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs fda.gov, Aug 18, 2006 to stop manufacturing and distributing thousands of doses of compounded, unapproved inhalation drugs nation-wide. Merck Wins New Jersey VIOXX Product Liability Case Press Release, Aug 04, 2006 rejecting the claims of a patient who blamed her heart attack on nearly three years of VIOXX use. AtriCure Receives FDA 510(k) Clearance Press Release, Jul 21, 2006 The new capabilities of this multifunctional Pen allow physicians to identify potential trigger areas on the heart that could cause cardiac arrhythmias. In New York, Counterfeit Prescription Drugs house.gov, Jun 23, 2006 Prescription drugs has significant loopholes that allow criminals to introduce counterfeits into our drug supply Cali Drug Cartel Leader Surrender To U.S. Authorities usdoj.gov, May 22, 2006 William Rodriguez-Abadia is one of the leaders of the infamous Cali Drug Cartel Ca Will Not Join Lawsuit Challenging Federal Prescription Drug Plan ag.ca.gov, May 09, 2006 The Bush prescription drug plan has left pharmaceutical firms and HMOs rolling in profits Pharmaceutical Drug Litigation On Foreign Wholesalers fda.gov, Apr 24, 2006 FDA is very concerned about the safety risks associated with the importation of prescription drugs from foreign countrie FDA Drug Recall Policies vm.cfsan.fda.gov, Apr 10, 2006 The guidelines categorize all recalls into one of three classes according to the level of hazard involved Medical News Development On Bowel Cleansing Products 4woman.gov, Mar 20, 2006 Bowel Cleansing Products Linked to Chronic Kidney Failure Public Citizen Petitions FDA to Ban Darvon Products FDA.gov, Mar 02, 2006 The drug has been associated with more than two thousand accidental deaths FDA Warns Consumers About Emagrece Sim Brazilian Diet Pill fda.gov, Feb 16, 2006 Emagrece Sim and Herbathin Dietary Supplements May be Harmful FDA Investigate Four Death Septic Shocks, Due To Use Of Abortifacient Mifeprex reform.house.gov, Feb 01, 2006 I am encouraged by the joint FDA-CDC effort to examine the serious health and public safety risks posed by RU-486 In Pennsylvania, 2005 Federal Sentencing Guidelines,Woman Admits Cocaine Possession usdoj.gov, Jan 17, 2006 The law provides for a total sentence of one year in prison, a fine of 1,000, or both FDA's New Jersey District Office Aims To Improve Company Drug Manufacturing FDA.Gov, Jan 03, 2006 Firm signs consent, agrees to record 500 million fine Federal Trafficking Of Drug Penalties For Cocaine dea.gov, Dec 20, 2005 Not less than 5 yrs, and not more than 40 yrs. If death or serious injury, not less than 20 or more than life New York Survey Reveals Continued Drug Price Prescription Disparities Across the State oag.state.ny.us/press, Nov 30, 2005 Surveyed 440 pharmacies in all 62 counties across the state to determine the prices of the 25 most commonly prescribed drugs FDA Updates Labeling for Ortho Evra Contraceptive Patch Enter Source, Nov 22, 2005 Increased estrogen exposure may increase the risk of blood clots States Sue To Stop Anti Generic Drug Collusion Ny.gov, Nov 18, 2005 Lawsuit Alleges Companies’ Agreement Precluded Competition for Oral Contraceptive In Michigan, Mandatory Drug Testing michigan.gov, Nov 14, 2005 The policy violated plaintiffs 4th Amendment rights because the testing was not suspicion based Permits A Patent Holder To Bring An Infringement Action Wlf.org, Oct 14, 2005 Adopts by reference the statement of the case set forth in the petition West Palm Beach Drug Enforcement usdoj.gov, Sep 15, 2005 West Palm Beach, Resident Agent In Charge, Port St. Lucie Office Of The Drug Enforcement Administration Brooklyn New York Litigation usdoj.gov, Sep 09, 2005 Brooklyn New York Three Israeli Conspiring To Distribute Of Tablets Nearly Two Years Litigation How Has The Hatch-Waxman Compromise house.gov, Aug 29, 2005 To permit the approval of generic copies of all post-1962 drugs, Jury Awards 253M to Widow in First Vioxx Case 4woman.gov, Aug 22, 2005 It was the first lawsuit in either state or federal court involving the now banned painkiller Drug Company Trade Group Pharmaceutical bernie.house.gov, Aug 09, 2005 Pharmaceutical Research And Manufacturers To Help Set Those Policies Deputy Chief Counsel For Litigation Named fda.gov, Aug 09, 2005 FDA Chief Counsel Margaret Jane Porter has announced the appointment of Eric M. Blumberg as Deputy Chief Counsel FDA Aims to Boost Safety of Approved Drugs healthfinder.gov, Aug 05, 2005 The U.S. Food and Drug Administration, facing a barrage of criticism from both within and outside the agency, announced plans Friday Recent Congressional Action On Generics Legislation hhs.gov, Jul 13, 2005 Both the Senate and the House have added generic drug access provisions to their versions of the Medicare bill, which have passed both chambers and are currently in confe Lawsuit Against Pfizer That Was Ongoing house.gov, Jun 30, 2005 FDA Get Involved In A Private State Lawsuit Against Pfizer That Was Ongoing In California Slew Of Lawsuits Will Target Vioxx Maker healthfinder.gov, Jun 22, 2005 Lawsuits Will Target Vioxx Maker Throngs of lawyers who represent people allegedly hurt or killed Amendments Were Intended To Balance Two Important Public Policy Goals judiciary.senate.gov, Jun 13, 2005 Congress wanted to ensure that brand-name (also known as innovator) drug manufacturers would have meaningful patent Permanently Enjoining It From Future Violations Of Section 17(a) sec.gov, Jun 13, 2005 Take-Two Consented To Entry Of A Final Judgment Permanently Enjoining It From Future Violations Of Section 17(a) Only Certain Types Of Patent hhs.gov, Jun 07, 2005 Only Certain Types Of Patent Information Can Be Submitted To FDA Benefits Of Pharmaceutical Innovation Would Continue energy commerce.house.gov, May 31, 2005 The Issue Of Escalating Drug Expenditures, And To Ensure That The Benefits Of Pharmaceutical Innovation Would Continue $22.7 Million Settlement With Medco Health attorney general gov, May 20, 2005 $22.7 Million Settlement With Medco Health Solutions Resolving Allegations Marijuana The Myths Are Killing Us usdoj, May 13, 2005 Marijuana The Myths Are Killing Us ACLU and Drug Policy Groups Sue Over Censorship of Advertisements Criticizing “War on Drugs change the climate, May 09, 2005 ACLU and Drug Policy Groups Sue Over Censorship of Advertisements Criticizing “War on Drugs FDA Proposed Rule On Generic Drugs FDA, Apr 28, 2005 This existing law attempts to strike a balance between providing incentives to develop innovative new drugs Prescription Drug Compliance a Significant Challenge for Many Patients press release, Mar 31, 2005 One in three (33%) U.S. adults who have been prescribed drugs to take on a regular basis report that they are often or very often noncompliant with their treatment regime Congressman questions FDA on Vioxx, Bextra and Celebrex House of Representatives, Mar 25, 2005 Rep. Markey Questions FDA Advisory Committee Decision to Ignore Potential Conflicts of Interest Louisiana Warns Patients Of Celebrex, Brextra Dangers Louisiana Department of Health and Hospitals, Mar 25, 2005 Medicaid Program Implements Patient Safeguards Against Potentially Dangerous Drugs On Duty Corrections Officer Believed To Be On Drugs Crashes Into Driver Press Release, Mar 18, 2005 corrections officer suspected of being impaired crashes into car CellTracks(R) Analyzer II Receives FDA 510(k) Clearance for In Vitro Diagnostic Use Press Release, Mar 17, 2005 CellTracks(R) Analyzer II Receives FDA 510(k) Clearance for In Vitro Diagnostic Use Accutane Benefits and Risks FDA, Mar 01, 2001 The benefits and risks of a breakthrough acne drug. For regional news articles, please visit state drug litigation resources. Contact a Drug Litigation Lawyer now for a free case review.

	Latest News
	FTC’s Bureau of Competition Issues Summary of... FTC, Jul 25, 2008 Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market... Read more > San Francisco Health Plan, Herrera Sue McKess... State of San Francisco, Jul 11, 2008 City Program is First Government Plaintiff in Federal Suit Alleging Multimillion Dollar Conspiracy to Hike Prices on Consumers, Providers... Read more > Walgreens to Pay $35 Million to U.S., 46 Stat... U.S. Department of Justice, Jun 17, 2008 The United States will not tolerate pharmacies or any other health care providers that attempt to manipulate the Medicaid program at the taxpayers... Read more > More Drug Litigation News >

Regional Resources

Alabama	Missouri
Alaska	Montana
Arizona	Nebraska
Arkansas	Nevada
California	New Hampshire
Colorado	New Jersey
Connecticut	New Mexico
DC	New York
Delaware	North Carolina
Florida	North Dakota
Georgia	Ohio
Hawaii	Oklahoma
Idaho	Oregon
Illinois	Pennsylvania
Indiana	Rhode Island
Iowa	South Carolina
Kansas	South Dakota
Kentucky	Tennessee
Louisiana	Texas
Maine	Utah
Maryland	Vermont
Massachusetts	Virginia
Michigan	Washington
Minnesota	West Virginia
Mississippi	Wisconsin
	Wyoming
Browse Map >

	Hot Topics
	Crestor Litigation Celebrex Litigation Bextra Litigation FDA and Drug Recalls Vioxx Litigation Prescription Drug Fraud

	Did You Know?
	Every Single Drug That Affects The Body Will Have Some Side Effects Since the Food and Drug Administration (FDA) considers both the benefits and risks of all medications before approval, side effects are generally not serious. For every drug FDA approves, the benefits are balanced against its risks.

Legal Disclaimers
All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on Drug Litigation Lawyers.com is not intended to be legal advice, but merely conveys general information related to legal issues commonly encountered. Please contact a local attorney in your area for official legal and law information. Your access to and use of this website is subject to additional Terms and Conditions.

Drug Litigation News & Articles